乙肝肝硬化失代偿期的药物治疗及临床效果评定

Drug Treatment and Clinical Effect Evaluation of Hepatitis B Cirrhosis in Patients With Cirrhosis

目的研究乙肝肝硬化失代偿期的药物治疗及临床效果。方法选取2013年2月～2015年12月我院收治乙肝肝硬化失代偿期患者32例。根据治疗方法分为对照组16例和研究组16例。对照组给予保肝、抗病毒等综合治疗,研究组在对照组基础上增加复方鳖甲软肝片治疗。对比疗效。结果研究组较之对照组肝功能谷氨酰转肽酶、谷丙转氨酶、球蛋白指标改善更显著,肝纤四项改善更显著,P〈0.05。结论肝硬化失代偿期在保肝、抗病毒等综合治疗基础上增加复方鳖甲软肝片治疗效果确切。

Objective To study the drug treatment and clinical effect of hepatitis B cirrhosis. Methods From February 2013 to December 2015 in our hospital were treated with hepatitis B cirrhosis of the 32 cases of patients with cirrhosis. According to the treatment method, 16 cases were divided into control group and 16 cases in the study group. The control group was given hepatoprotective and antiviral treatment, research group increased fufangbiejiaruangan treatment group based on. Contrast effect of two groups. Results The study group compared with the control group, liver function glutamyltranspetidase, alanine aminotransferase, globulin index improved more significantly, four liver improved more significantly, P〈0.05. Conclusion Decompensated liver cirrhosis based on liver, antiviral and other comprehensive treatment on fufangbie jiaruangan treatment.